Sinchun Hwang

10PUBLICATIONS
61CO-AUTHORS
Molecular targetsPharmaceutical delivery technologiesSolid tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 22, 2025
ctDNA as a Molecular Biomarker in the Phase II Trial of Imatinib plus Binimetinib in Patients with Advanced Gastrointestinal Stromal Tumor.

Ciara M Kelly, Martina Bradic, Sara Saunds

|May 07, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results.

Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz

|Jun 17, 2024
Modeling Extraordinary Response Through Targeting Secondary Alterations in Fusion-Associated Sarcoma.

Fabio Vanoli, Evan Song, Josephine K Dermawan

|Mar 27, 2023
A Phase II Study of Epacadostat and Pembrolizumab in Patients with Advanced Sarcoma.

Ciara M Kelly, Li-Xuan Qin, Karissa A Whiting

|Jul 19, 2022
The 2020 World Health Organization classification of bone tumors: what radiologists should know.

Sinchun Hwang, Meera Hameed, Mark Kransdorf

|Jul 07, 2022
DICER1-Associated Anaplastic Sarcoma of the Kidney With Coexisting Activating PDGFRA D842V Mutations and Response to Targeted Kinase Inhibitors in One Patient.

Cristina R Antonescu, Victor E Reuter, Mary Lou Keohan

Pageof 2

Frequent Collaborators

6 joint publications

Cristina R Antonescu

6 joint publications

Evan Rosenbaum

6 joint publications

Ciara M Kelly

6 joint publications

William D Tap